About Unique Pharmaceuticals
Unique Pharmaceuticals is a Healthcare company based in Lagos (Nigeria). It manufactures and distributes quality I.V. fluids, tablets, and drugs in Nigeria. It operates on a B2B model. Its Indian entity Unique Pharmaceutical Laboratories Limited reported revenue of ₹12.98 Cr. Unique Pharmaceuticals offers products and services including UNIDEX-5, LOTEMP SUSPENSION, UNIDEX-10, ACIGUARD TABLETS, and EXIPLON SYRUP. Its focus areas include Pharmaceuticals, Distribution, Medical Supplies and Manufacturing.
Company details
Unique Pharmaceuticals Limited, established in 1988 in Nigeria, specializes in manufacturing and distributing pharmaceutical products such as I.V. fluids, oral liquids, tablets, and ointments using advanced Form-Fill-Seal technology. Based in Sango-Ota with nationwide distribution centers, it employs over 750 people and serves more than 500 customers in the healthcare sector, focusing on quality and compliance with global standards.
- Headquarters Lagos, Nigeria
- SectorsHealthcare
- Phone•••• ••••
- Website uniquepharm.com
- Social LinkedIn
- Legal Name Unique Pharmaceutical Laboratories Limited
- Date of Incorporation 11 Apr, 1972
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹12.98 Cr
FY 2025 · +22% YoY
- Net Profit₹48.4 Lakh
FY 2025 · 4% margin
- EBITDA₹81.9 Lakh
FY 2025 · 6% margin
Associated legal entities of Unique Pharmaceuticals
Unique Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Unique Pharmaceutical Laboratories Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unique Pharmaceutical Laboratories Limited CIN U47722MH1972PLC015744 | Active | 11 Apr 1972 | Mumbai, Maharashtra | ₹13.0 Cr | – | 4 | View details |
| Unique Pharmaceutical Laboratories Limited CIN U24239MH1972PLC015744 | – | 11 Apr 1972 | Mumbai, Maharashtra, India | – | – | – | View details |
Products & Services of Unique Pharmaceuticals
Unique Pharmaceuticals offers a comprehensive portfolio of products and services, including UNIDEX-5, LOTEMP SUSPENSION, UNIDEX-10, ACIGUARD TABLETS, and EXIPLON SYRUP.
Intravenous dextrose solution for hydration and energy.
Relieves pain and reduces fever in liquid form.
Higher concentration dextrose for medical use.
Treats acid reflux and ulcers effectively.
Alleviates cough and respiratory symptoms.
Supplements iron and vitamins for blood health.
Board of directors of Unique Pharmaceutical Laboratories Limited (Unique Pharmaceuticals)
Unique Pharmaceutical Laboratories Limited is the primary company behind Unique Pharmaceuticals. The board of Unique Pharmaceutical Laboratories Limited currently have 4 directors; the longest-serving is Bharat Pravinchandra Mehta, appointed in 1981. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bharat Pravinchandra Mehta DIN 00035444 | Director | 17 Jan 1981 | 45 yrs 9 mo | Unique Pharmaceutical Laboratories Limited |
| Jay Bharat Mehta DIN 00043079 | Director | 23 Dec 2020 | 5 yrs 9 mo | Unique Pharmaceutical Laboratories Limited |
| Pallavi Bharat Mehta DIN 00043212 | Director | 19 Aug 2025 | 1 yr 2 mo | Unique Pharmaceutical Laboratories Limited |
| Shilpi Jay Mehta DIN 01674052 | Director | 19 Aug 2025 | 1 yr 2 mo | Unique Pharmaceutical Laboratories Limited |
Financials of Unique Pharmaceuticals
Figures of Unique Pharmaceutical Laboratories Limited, the primary company behind Unique Pharmaceuticals, for FY 2025. Revenue was ₹12.98 Cr (+22% year on year). Net profit was ₹48.4 Lakh (4% margin). EBITDA was ₹81.9 Lakh (6% margin). Revenue has grown at a compounded annual rate of +73% over three years and -10% over five years.
- ₹12.98 CrRevenue · FY 2025 · +22% YoY
- ₹48.4 LakhNet profit · 4% margin
- ₹81.9 LakhEBITDA · 6% margin
- ₹8.7 LakhPaid-up capital
- +73%Revenue CAGR, 3 years
- -10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Unique Pharmaceutical Laboratories Limited are on its company page.
Detailed financial statements for Unique Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Unique Pharmaceuticals
The website of Unique Pharmaceuticals (uniquepharm.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 141.4% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Unique Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Unique Pharmaceuticals
Unique Pharmaceuticals is headquartered in Lagos, Nigeria. It is registered at Lagos, Lagos State, Nigeria.
The primary company behind Unique Pharmaceuticals, Unique Pharmaceutical Laboratories Limited, reported revenue of ₹12.98 Cr for FY 2025, up 22% year on year.
Unique Pharmaceuticals Limited, established in 1988 in Nigeria, specializes in manufacturing and distributing pharmaceutical products such as I.V. fluids, oral liquids, tablets, and ointments using advanced Form-Fill-Seal technology. Based in Sango-Ota with nationwide distribution centers, it employs over 750 people and serves more than 500 customers in the healthcare sector, focusing on quality and compliance with global standards.
Unique Pharmaceuticals offers UNIDEX-5, LOTEMP SUSPENSION, UNIDEX-10, ACIGUARD TABLETS, and 2 more products and services.
Unique Pharmaceuticals operates through Unique Pharmaceutical Laboratories Limited.
The legal entities of Unique Pharmaceuticals currently have 4 directors, including Bharat Pravinchandra Mehta, Pallavi Bharat Mehta, Shilpi Jay Mehta and others.